AI assistant
BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2011
May 5, 2011
30583_dirs_2011-05-05_11307ca7-3ab0-4710-8a1d-da92af6378ba.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2011-04-29
Reporting Person: BIENAIME JEAN JACQUES (Director, Chief Executive Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-04-29 | Common Stock | A | 1826 | $11.637 | Acquired | 91893 | Direct |
| 2011-05-03 | Common Stock | M | 3000 | $9.86 | Acquired | 94893 | Direct |
| 2011-05-03 | Common Stock | S | 3000 | $26.6821 | Disposed | 91893 | Direct |
| 2011-05-03 | Common Stock | S | 2000 | $27.11 | Disposed | 89893 | Direct |
| 2011-05-04 | Common Stock | M | 1000 | $9.86 | Acquired | 90893 | Direct |
| 2011-05-04 | Common Stock | S | 1000 | $25.844 | Disposed | 89893 | Direct |
| 2011-05-04 | Common Stock | S | 1700 | $26.296 | Disposed | 88193 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-05-03 | Stock Option (right to buy) | $9.86 | M | 3000 | Disposed | 2015-11-10 | Common Stock (3000) | Direct |
| 2011-05-04 | Stock Option (right to buy) | $9.86 | M | 1000 | Disposed | 2015-11-10 | Common Stock (1000) | Direct |
Footnotes
F1: The reporting person is voluntarily reporting the acquisition of shares of the issuer's common stock pursuant to the issuer's Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of November 1, 2010 to April 29, 2011.
F2: The price in Column 4 is a weighted average price. The prices actually received ranged from $26.69 to $26.684. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F3: The price in Column 4 is a weighted average price. The prices actually received ranged from $25.891 to $26.35. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F4: Original option granted on November 11, 2005 and vests equally 1/3 each on May 11, 2006, May 11, 2007, and May 27, 2008.